With advanced haematology and oncology infrastructure, Fortis Malar Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 1989, the NABH accredited hospital is located in Chennai, India, and has 180 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.